JENNIFER RANDALL: Open Payments
NPI 1447944954 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 83 payments from 17 companies in 2025. Trend: 2023 $1,139 · 2024 $2,200 · 2025 $1,228
Food & beverage: $1,228
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $252 |
| ABBVIE INC. | 16 | $203 |
| Alkermes, Inc. | 8 | $148 |
| Neurocrine BioSciences, Inc. | 4 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| Tris Pharma Inc | 4 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, INGREZZA, REXULTI, COBENFY, FANAPT, Jornay PM.
Industry payments across FL — which companies pay providers there.
